Medicine Man Technologies Reports Officer/Director Changes
| Field | Detail |
|---|---|
| Company | Medicine Man Technologies, Inc. |
| Form Type | 8-K |
| Filed Date | Apr 21, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, officer-appointment, director-election, financials
TL;DR
Med Man Tech (MDMG) filed an 8-K for officer/director changes and comp arrangements as of April 15th.
AI Summary
Medicine Man Technologies, Inc. filed an 8-K on April 21, 2025, reporting events as of April 15, 2025. The filing pertains to the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. It also includes financial statements and exhibits.
Why It Matters
This filing indicates potential shifts in the company's leadership and governance structure, which could impact strategic direction and operational oversight.
Risk Assessment
Risk Level: medium — Changes in key personnel and executive compensation can signal internal shifts that may affect future performance or strategy.
Key Players & Entities
- Medicine Man Technologies, Inc. (company) — Registrant
- April 15, 2025 (date) — Earliest event reported
- April 21, 2025 (date) — Date of report
- Nevada (jurisdiction) — State of incorporation
- 865 N. Albion St. Ste. 300 Denver, Colorado 80220 (address) — Principal executive offices
FAQ
What specific officer or director positions were affected by the changes reported in this 8-K?
The filing indicates "Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers" but does not specify the names or exact positions in the provided text.
Were there any new directors or officers appointed as of April 15, 2025?
The filing states "Election of Directors; Appointment of Certain Officers" as an item of disclosure, implying that such events may have occurred.
What is the nature of the compensatory arrangements discussed in the filing?
The filing lists "Compensatory Arrangements of Certain Officers" as a disclosed item, but the details of these arrangements are not provided in the excerpt.
Does this 8-K filing include updated financial statements?
Yes, the filing explicitly lists "Financial Statements and Exhibits" as part of the report.
What is the primary business of Medicine Man Technologies, Inc. according to the filing?
The filing lists the Standard Industrial Classification as "SERVICES-MANAGEMENT CONSULTING SERVICES [8742]".
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 21, 2025 regarding Medicine Man Technologies, Inc..